These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20527994)

  • 1. Cost of myocardial infarction to the Australian community: a prospective, multicentre survey.
    Ioannides-Demos LL; Makarounas-Kirchmann K; Ashton E; Stoelwinder J; McNeil JJ
    Clin Drug Investig; 2010; 30(8):533-43. PubMed ID: 20527994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data.
    Margolis J; Barron JJ; Grochulski WD
    J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource Use and Burden of Hospitalization, Outpatient, Physician, and Drug Costs in Short- and Long-term Care After Acute Myocardial Infarction.
    Tran DT; Welsh RC; Ohinmaa A; Thanh NX; Kaul P
    Can J Cardiol; 2018 Oct; 34(10):1298-1306. PubMed ID: 30170782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct medical charges associated with myocardial infarction in patients with and without diabetes.
    Smith TL; Melfi CA; Kesterson JA; Sandmann BJ; Kotsanos JG
    Med Care; 1999 Apr; 37(4 Suppl Lilly):AS4-11. PubMed ID: 10217387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry.
    Cowper PA; Knight JD; Davidson-Ray L; Peterson ED; Wang TY; Mark DB;
    J Am Heart Assoc; 2019 Apr; 8(8):e011322. PubMed ID: 30975005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
    Tung CY; Granger CB; Sloan MA; Topol EJ; Knight JD; Weaver WD; Mahaffey KW; White H; Clapp-Channing N; Simoons ML; Gore JM; Califf RM; Mark DB
    Circulation; 1999 Jan; 99(3):370-6. PubMed ID: 9918523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J; Lingohr-Smith M; Kwong WJ
    J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a new short-stay unit to "rule out" acute myocardial infarction in low risk patients.
    Gaspoz JM; Lee TH; Weinstein MC; Cook EF; Goldman P; Komaroff AL; Goldman L
    J Am Coll Cardiol; 1994 Nov; 24(5):1249-59. PubMed ID: 7930247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the Impact of Rehospitalization on Healthcare Cost of Myocardial Infarction Patients in Beijing: A Retrospective Observational Study.
    Yang L; Liu Y; Wen L; Wu J
    Adv Ther; 2017 Jan; 34(1):109-119. PubMed ID: 27864667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.
    Magnuson EA; Li H; Wang K; Vilain K; Shafiq A; Bonaca MP; Bhatt DL; Cohen M; Steg PG; Storey RF; Braunwald E; Sabatine MS; Cohen DJ;
    J Am Coll Cardiol; 2017 Aug; 70(5):527-538. PubMed ID: 28750695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect costs of myocardial infarction in Portugal.
    Timóteo AT; Gouveia M; Soares C; Cruz Ferreira R
    Rev Port Cardiol (Engl Ed); 2020 May; 39(5):245-251. PubMed ID: 32505635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)].
    Philippe F; Blin P; Bouée S; Laurendeau C; Torreton E; Gourmelin J; Velkovski-Rouyer M; Levy-Bachelot L; Steg G
    Ann Cardiol Angeiol (Paris); 2017 Apr; 66(2):74-80. PubMed ID: 28139200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study.
    de Graaff B; Neil A; Sanderson K; Yee KC; Palmer AJ
    Aust Health Rev; 2017 Jul; 41(3):254-267. PubMed ID: 27444148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
    Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
    Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the clinical and economic burden of coronary artery disease: 1986-1998.
    Eisenstein EL; Shaw LK; Anstrom KJ; Nelson CL; Hakim Z; Hasselblad V; Mark DB
    Med Care; 2001 Aug; 39(8):824-35. PubMed ID: 11468501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medico-economic impact of the Program of Medicalization of the Information System on hospital stay for myocardial infarction: influence of the quality of data collection and hospitalization length].
    Gatin A; Budlot A; Bismuth MJ; Binquet C; Vour'ch M; Zeller M; Cottin Y; L'Huillier I; Bourgogne H; Louis P; Grenard M; Henriot B; Quantin C; Wolf JE
    Ann Cardiol Angeiol (Paris); 2001 Jun; 50(4):189-96. PubMed ID: 12555591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry study.
    Janzon M; Henriksson M; Hasvold P; Hjelm H; Thuresson M; Jernberg T
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):291-298. PubMed ID: 29474723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.